Status:
COMPLETED
Mini-PNCL vs fURS in Management of Nephrolithiasis
Lead Sponsor:
Thunder Bay Regional Health Research Institute
Conditions:
Nephrolithiasis
Kidney Stone
Eligibility:
All Genders
18+ years
Phase:
NA
Brief Summary
The prevalence of nephrolithiasis is increasing over the last two decades, and kidney stones is a recurrent disorder, with lifetime recurrence risks reported to be as high as 50%. One of the most chal...
Detailed Description
The prevalence of nephrolithiasis is increasing over the last two decades, and kidney stones is a recurrent disorder, with lifetime recurrence risks reported to be as high as 50%. One of the most chal...
Eligibility Criteria
Inclusion
- Male and female subjects over 18 years of age at the time of enrollment.
- Patients referred with single kidney stones of 10-20 mm in its largest diameter, or multiple stones involving a single calyx.
- Written informed consent to participate in the study
- Ability to comply with the requirements of the study procedures
Exclusion
- Congenital anatomic anomalies of the kidney, ureters or bladder.
- Previous ipsilateral renal surgery within past five years.
- Patients with ipsilateral distal ureteral stones or stricture.
- Stone size \> 20 mL or multiple kidney stones in different calyces.
- Previous SWL treatment for the same stone.
- Patients presented with a previously inserted ipsilateral ureteral stent.
- Participants with active urinary tract infection until appropriately treated
- Uncorrected coagulopathy (anticoagulants or blood thinners which cannot be withheld before surgery).
- Pregnancy or morbid obesity
- Participants with preexisting conditions, which, in the opinion of the investigator, interfere with the conduct of the study.
- Participants who are uncooperative or cannot follow instructions.
- Participants who lack the capacity to provide free and informed written consent.
- Patients with solitary kidney.
Key Trial Info
Start Date :
October 5 2020
Trial Type :
INTERVENTIONAL
Allocation :
ACTUAL
End Date :
April 24 2024
Estimated Enrollment :
76 Patients enrolled
Trial Details
Trial ID
NCT04389853
Start Date
October 5 2020
End Date
April 24 2024
Last Update
August 16 2024
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Thunder Bay Regional Health Sciences Centre/Thunder Bay Regional Health Research Institute
Thunder Bay, Ontario, Canada, P7B6V4